1. Home
  2. NOTV vs NMT Comparison

NOTV vs NMT Comparison

Compare NOTV & NMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOTV
  • NMT
  • Stock Information
  • Founded
  • NOTV 1974
  • NMT 1993
  • Country
  • NOTV United States
  • NMT United States
  • Employees
  • NOTV N/A
  • NMT N/A
  • Industry
  • NOTV Biotechnology: Pharmaceutical Preparations
  • NMT Finance/Investors Services
  • Sector
  • NOTV Health Care
  • NMT Finance
  • Exchange
  • NOTV Nasdaq
  • NMT Nasdaq
  • Market Cap
  • NOTV 137.5M
  • NMT 110.6M
  • IPO Year
  • NOTV 1997
  • NMT N/A
  • Fundamental
  • Price
  • NOTV $1.64
  • NMT $11.41
  • Analyst Decision
  • NOTV Strong Buy
  • NMT
  • Analyst Count
  • NOTV 3
  • NMT 0
  • Target Price
  • NOTV $5.92
  • NMT N/A
  • AVG Volume (30 Days)
  • NOTV 1.2M
  • NMT 19.1K
  • Earning Date
  • NOTV 05-09-2025
  • NMT 01-01-0001
  • Dividend Yield
  • NOTV N/A
  • NMT 3.21%
  • EPS Growth
  • NOTV N/A
  • NMT N/A
  • EPS
  • NOTV N/A
  • NMT N/A
  • Revenue
  • NOTV $475,114,000.00
  • NMT N/A
  • Revenue This Year
  • NOTV $6.07
  • NMT N/A
  • Revenue Next Year
  • NOTV $5.74
  • NMT N/A
  • P/E Ratio
  • NOTV N/A
  • NMT N/A
  • Revenue Growth
  • NOTV N/A
  • NMT N/A
  • 52 Week Low
  • NOTV $1.15
  • NMT $9.05
  • 52 Week High
  • NOTV $6.48
  • NMT $10.93
  • Technical
  • Relative Strength Index (RSI)
  • NOTV 38.13
  • NMT 41.29
  • Support Level
  • NOTV $1.15
  • NMT $10.90
  • Resistance Level
  • NOTV $1.85
  • NMT $11.48
  • Average True Range (ATR)
  • NOTV 0.44
  • NMT 0.20
  • MACD
  • NOTV -0.05
  • NMT -0.03
  • Stochastic Oscillator
  • NOTV 28.16
  • NMT 49.04

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

About NMT Nuveen Massachusetts Quality Municipal Income Fund

Nuveen Massachusetts Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's objective seeks to provide current income exempt from both regular federal and Massachusetts income taxes by investing in a portfolio of municipal obligations issued by state and local government authorities within a single state or certain U.S. territories.

Share on Social Networks: